Life Insurance [LICI] vs Niva Bupa Health [NIVABUPA] Detailed Stock Comparison
Life Insurance
NSE
Loading...
Niva Bupa Health
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Life Insurance wins in 11 metrics, Niva Bupa Health wins in 5 metrics, with 0 ties. Life Insurance appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Life Insurance | Niva Bupa Health | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.84 | 105.25 | Life Insurance |
| Price-to-Book Ratio | 5.09 | 4.44 | Niva Bupa Health |
| Debt-to-Equity Ratio | 0.00 | 7.71 | Life Insurance |
| PEG Ratio | 15.09 | 0.61 | Niva Bupa Health |
| EV/EBITDA | 9.99 | 54.22 | Life Insurance |
| Profit Margin (TTM) | 6.25% | 2.01% | Life Insurance |
| Operating Margin (TTM) | 9.58% | -6.66% | Life Insurance |
| EBITDA Margin (TTM) | 9.58% | N/A | N/A |
| Return on Equity | 52.88% | 4.75% | Life Insurance |
| Return on Assets (TTM) | 0.65% | 2.19% | Niva Bupa Health |
| Free Cash Flow (TTM) | $-99.22B | $16.13B | Niva Bupa Health |
| Dividend Yield | 1.31% | N/A | N/A |
| 1-Year Return | -19.45% | 8.07% | Niva Bupa Health |
| Price-to-Sales Ratio (TTM) | 0.65 | 2.27 | Life Insurance |
| Enterprise Value | $5,779.95B | $146.48B | Life Insurance |
| EV/Revenue Ratio | 0.65 | 2.26 | Life Insurance |
| Revenue per Share (TTM) | $1,223 | $36 | Life Insurance |
| Earnings per Share (Diluted) | $77.08 | $0.76 | Life Insurance |
| Beta (Stock Volatility) | 0.53 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Life Insurance vs Niva Bupa Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Life Insurance | 3.16% | 3.18% | -3.58% | 16.77% | 12.86% | 1.85% |
| Niva Bupa Health | -0.47% | -1.86% | -4.51% | -8.37% | -1.86% | -4.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Life Insurance | -19.45% | 33.79% | 11.76% | 11.76% | 11.76% | 11.76% |
| Niva Bupa Health | 8.07% | 8.07% | 8.07% | 8.07% | 8.07% | 8.07% |
Performance & Financial Health Analysis: Life Insurance vs Niva Bupa Health
| Metric | LICI | NIVABUPA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.78T | ₹147.59B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 1,061,495 | 2,486,686 |
| 90 Day Avg. Volume | 874,268 | 3,862,454 |
| Last Close | ₹912.95 | ₹79.99 |
| 52 Week Range | ₹715.30 - ₹1,160.00 | ₹68.54 - ₹109.34 |
| % from 52W High | -21.30% | -26.84% |
| All-Time High | ₹1,222.00 (Jul 29, 2024) | ₹109.34 (Dec 02, 2024) |
| % from All-Time High | -25.29% | -26.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.14% |
| Quarterly Earnings Growth | 0.41% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.02% |
| Operating Margin (TTM) | 0.10% | -0.07% |
| Return on Equity (TTM) | 0.53% | 0.05% |
| Debt to Equity (MRQ) | 0.00 | 7.71 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹179.36 | ₹18.02 |
| Cash per Share (MRQ) | ₹98.52 | ₹1.21 |
| Operating Cash Flow (TTM) | ₹-91,447,697,408 | N/A |
| Levered Free Cash Flow (TTM) | ₹359.01B | ₹2.14B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.31% | N/A |
| Last 12-Month Dividend | ₹12.00 | N/A |
Valuation & Enterprise Metrics Analysis: Life Insurance vs Niva Bupa Health
| Metric | LICI | NIVABUPA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.84 | 105.25 |
| Forward P/E | 15.09 | 50.76 |
| PEG Ratio | 15.09 | 0.61 |
| Price to Sales (TTM) | 0.65 | 2.27 |
| Price to Book (MRQ) | 5.09 | 4.44 |
| Market Capitalization | ||
| Market Capitalization | ₹5.78T | ₹147.59B |
| Enterprise Value | ₹5.78T | ₹146.48B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.65 | 2.26 |
| Enterprise to EBITDA | 9.99 | 54.22 |
| Risk & Other Metrics | ||
| Beta | 0.53 | N/A |
| Book Value per Share (MRQ) | ₹179.36 | ₹18.02 |
Financial Statements Comparison: Life Insurance vs Niva Bupa Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LICI | NIVABUPA |
|---|---|---|
| Revenue/Sales | ₹2.15T | ₹13.71B |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | ₹188.46B | ₹-914.40M |
| Income Tax | ₹-232.10M | ₹0 |
| Net Income (Profit) | ₹188.70B | ₹-914.40M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LICI | NIVABUPA |
|---|---|---|
| Cash & Equivalents | ₹698.85B | ₹2.20B |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | N/A | ₹2.50B |
| Total Shareholders Equity | ₹1.28T | ₹44.94B |
| Retained Earnings | N/A | ₹7.18B |
| Property, Plant & Equipment | N/A | ₹292.30M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LICI | NIVABUPA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | ₹-733.26M | ₹-9.31M |
| Free Cash Flow | ₹56.69B | ₹701.20M |
| Debt Repayment | ₹0 | ₹0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LICI | NIVABUPA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,061,495 | 2,486,686 |
| Average Daily Volume (90 Day) | 874,268 | 3,862,454 |
| Shares Outstanding | 6.32B | 1.83B |
| Float Shares | 248.27M | 605.39M |
| % Held by Insiders | 0.97% | 0.76% |
| % Held by Institutions | 0.01% | 0.14% |
Dividend Analysis & Yield Comparison: Life Insurance vs Niva Bupa Health
| Metric | LICI | NIVABUPA |
|---|---|---|
| Last 12-Month Dividend | ₹12.00 | N/A |
| Last 12-Month Dividend Yield | 1.31% | N/A |
| 3-Year Avg Annual Dividend | ₹9.83 | N/A |
| 3-Year Avg Dividend Yield | 0.57% | N/A |
| 3-Year Total Dividends | ₹29.50 | N/A |
| Ex-Dividend Date | Jul 25, 2025 | N/A |